IRIS

ARPINO, GRAZIA

ARPINO, GRAZIA  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 156 (tempo di esecuzione: 0.052 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy. 1.1 Articolo in rivista 2007 Arpino, Grazia; Carolina, Gutierrez; Heidi, Weiss; Mothaffar, Rimawi; Suleiman, Massarweh; Lavina, Bharwani; DE PLACIDO, Sabino; C., Kent Osborne; Rachel, Schiff
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. 1.1 Articolo in rivista 2005 Arpino, Grazia; Weiss, H; Lee, Av; Schiff, R; DE PLACIDO, Sabino; Osborne, Ck; Elledge, Rm
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. 1.1 Articolo in rivista 2005 Arpino, Grazia; Weiss, H; Lee, Av; Schiff, R; DE PLACIDO, Sabino; Osborne, Ck; Elledge, R. M.
GMO-Gestione Malattie Oncologiche in Regione Campania. 2.1 Contributo in volume (Capitolo o Saggio) 2011 Arpino, Grazia; Cammarota, Simona; DE ANGELIS, Carmine; Pizzi, Claudia; Perone, Vincenzo; Tommasielli, Giuseppina; Arpino, Giovanni; Novellino, Ettore; DE PLACIDO, Sabino
Progesterone receptor (PgR) status provides additional information to estrogen receptor (ER) status for predicting clinical outcomes of primary breast cancer patients treated with adjuvant endocrine therapy. 4.1 Articoli in Atti di convegno 2002 V. J., Bardou; Arpino, Grazia; R. M., Elledge; G. M., Clark
HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study. 1.1 Articolo in rivista 2004 Arpino, Grazia; Stephanie J., Green; D., Craig Allred; Dannika, Lew; Silvana, Martino; C., Kent Osborne; Richard M., Elledge
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study 1.1 Articolo in rivista 2013 Carlo, Lazzaro; Roberto, Bordonaro; Francesco, Cognetti; Fabi, ; DE PLACIDO, Sabino; Marchetti, Botticelli; Pronzato, Martelli; Arpino, Grazia
Potent inhibition of EGFR(ErbB1)/HER2 (ErbB2) pathway plus estrogen deprivation is a superior therapeutic combination in ER positive HER2-neu Over-expressing breast tumor xenografts. 4.1 Articoli in Atti di convegno 2006 M. F., Rimawi; H. L., Weiss; Arpino, Grazia; G. S., Morris; R. D., Soliz; R. M., Ward; T. M., Gilmer; C. K., Osborne; R., Schiff
HER-2 amplification, EGFR expression, and tamoxifen response in ER-positive metastatic breast cancer; a SWOG study 4.1 Articoli in Atti di convegno 2002 Arpino, Grazia; S., Green; Dc, Allred; P., Ravdin; D., Lew; S., Martino; Ck, Osborne; R., Elledge
Prognostic and predictive factors in breast cancer, an evidence-based medicine approach 2.1 Contributo in volume (Capitolo o Saggio) 2002 Mohsin, Sk; Bardou, Vj; Arpino, Grazia; Chamness, Gc; Allred, Dc
A Feasibilty Study of a Sequential Dose-Dense Adjuvant Regimen with Epidoxorubicin Followed by Docetaxel Followed by High-Dose Cyclophosphamide for Early Breast Cancer with 4 or More Lymph Node Metastases. 4.1 Articoli in Atti di convegno 2001 Francesco, Cognetti; Arpino, Grazia; DE LAURENTIIS, Michelino; Paola, Papaldo; Chiara, Sguotti; Modesto, D'Aprile; Francesco, Recchia; DE PLACIDO, Sabino; Angelo Raffaele, Bianco
Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) on core needle biopsy (CNB) — Clinical significance 4.1 Articoli in Atti di convegno 2003 Arpino, Grazia; C., Allred; S., Mohsin; H., Weiss; D., Conrow; R., Elledge
Triple-negative breast cancers: Biomarkers and outcomes 4.1 Articoli in Atti di convegno 2010 Malorni, L.; Shetty, P. B.; Hilsenbeck, S. G.; Rimawi, M. F.; Elledge, R. M.; De Angelis, C.; Osborne, C. K.; DE PLACIDO, Sabino; Arpino, Grazia
A Metanalysis on the Interaction between HER2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer 1.1 Articolo in rivista 2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, Chiara; Ciardiello, F; Tortora, G; D’Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, R; Bianco, Ar; DE PLACIDO, Sabino
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer. 1.1 Articolo in rivista 2005 Arpino, Grazia; D. R., Ciocca; H., Weiss; D. C., Allred; P., Daguerre; L., Vargas Roig; M., Leuzzi; F., Gago; R., Elledge; S. K., Mohsin
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. 1.1 Articolo in rivista 2003 Valerie Jeanne, Bardou; Arpino, Grazia; Richard M., Elledge; C., Kent Osborne; Gary M., Clark
Premalignant and in situ breast disease: biology and clinical implications. 1.1 Articolo in rivista 2005 Arpino, Grazia; Rodolfo, Laucirica; Richard M., Elledge
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. 1.1 Articolo in rivista 2004 Arpino, Grazia; Valerie J., Bardou; Gary M., Clark; Richard M., Elledge
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen. 1.1 Articolo in rivista 2005 Arpino, Grazia; H. L., Weiss; G. M., Clark; S. G., Hilsenbeck; C. K., Osborne
Lobular neoplasia on core-needle biopsy--clinical significance. 1.1 Articolo in rivista 2004 Arpino, Grazia; D., Craig Allred; Syed Khalid, Mohsin; Heidi L., Weiss; David, Conrow; Richard M., Elledge